ANNALS OF THE RHEUMATIC DISEASES, published by BMJ Publishing Group, stands as a leading academic journal in the realm of rheumatology and related fields, including biochemistry, immunology, and genetics. With an esteemed impact factor and a consistent ranking in the upper echelons of its category (Q1) as per the latest evaluations, this journal represents the forefront of research and innovation, fostering scientific advancement from 1945 to the present. As the top journal in the Medicine - Rheumatology category and achieving remarkable percentiles in various interdisciplinary categories, it serves as a critical platform for researchers, clinicians, and students dedicated to understanding and addressing rheumatic diseases. Although it does not currently offer open access, its rigorous peer-review process ensures the dissemination of high-quality research findings that are paramount in enhancing clinical practices and advancing scientific discourse. Readers can expect to be challenged and inspired by the breadth of studies and reviews that address the complexities of rheumatology and its intersecting scientific domains.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS is a distinguished peer-reviewed journal published by KARGER, based in Switzerland. With a focus on the critical fields of cognitive neuroscience, geriatrics, and psychiatry, this journal is integral to advancing our understanding of cognitive decline and geriatric health. Despite being established from 1990 through 1992 and relaunching its scope in 1994, it has consistently provided a platform for innovative research, as reflected in its strong impact factor and notable Scopus rankings, placing it in the Q2 quartile for disciplines including cognitive neuroscience and geriatric medicine. The journal aims to foster interdisciplinary dialogue and collaboration among researchers, healthcare professionals, and educators, contributing to the growing field of dementia research and elderly care. Open access options further ensure that this vital knowledge is widely accessible, making a significant impact in both academic and clinical settings. With a commitment to quality and relevance, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS remains a key resource for those dedicated to understanding and addressing the challenges posed by cognitive disorders in aging populations.

Current Treatment Options in Rheumatology, published by SPRINGERNATURE, is a pivotal journal focused on advancing the field of rheumatology through the dissemination of cutting-edge research and comprehensive reviews. With an emphasis on current therapeutic strategies, this journal aims to provide healthcare professionals, researchers, and students with up-to-date information on the latest treatment modalities for rheumatic diseases. Although it operates under a subscription model, it offers a platform for sharing significant findings that can influence clinical practice and policy within the field of rheumatology. By promoting insightful discussions and collaborations, Current Treatment Options in Rheumatology plays a crucial role in shaping the future of rheumatic disease management and improving patient outcomes.

American Journal of Geriatric Psychiatry, published by Elsevier Science Inc, stands as a leading journal in the fields of geriatrics and gerontology, as well as psychiatry and mental health, recognized with a Q1 ranking in both categories for 2023. With a robust ISSN of 1064-7481 and E-ISSN 1545-7214, this journal has been a vital resource since its inception in 1993, contributing to the academic discourse surrounding the mental health of older adults. The journal focuses on publishing high-quality research and reviews that address the complexities of psychiatric disorders in geriatric populations, making it essential reading for researchers, professionals, and students dedicated to enhancing the mental well-being of elderly individuals. Notably, it achieves impressive Scopus rankings, sitting at the 5th percentile in Geriatrics and Gerontology and 24th percentile in Psychiatry and Mental Health, underscoring its impact and relevance in the academic community. While it does not offer open access, the journal's comprehensive content is vital for those looking to stay informed on the latest advancements in geriatric psychiatry. For more information, readers can access it via Elsevier's educational platforms.

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

Journal of Alzheimer's Disease Reports, published by IOS PRESS, is an essential open-access platform dedicated to advancing research in the fields of clinical psychology, geriatrics, gerontology, neuroscience, and psychiatry. Since its inception in 2017, this journal has rapidly gained recognition, achieving a commendable status reflected in its 2023 category quartiles, notably ranking Q2 in Clinical Psychology and Psychiatry and Mental Health. With a sustained commitment to disseminating high-quality research and facilitating collaboration among scientists, the journal offers insights into the critical aspects of Alzheimer's disease and related cognitive disorders. Given its positions in the Scopus ranks, it serves as a crucial resource for academics and practitioners alike, empowering them to contribute effectively to the ongoing discourse in cognitive health. The journal embraces open access, ensuring that all research findings are freely available to the global community, thereby enhancing visibility and engagement. With a focus on fostering innovation and knowledge transfer, Journal of Alzheimer's Disease Reports is poised to make an enduring impact in the field of dementia research.

International Journal of Geriatric Psychiatry, published by Wiley, stands as a premier journal dedicated to advancing the field of mental health in older adults. With an impressive impact factor reflective of its Q1 categorization in both Geriatrics and Gerontology, as well as Psychiatry and Mental Health, this journal addresses the critical intersection of aging and mental health, providing a platform for impactful research from 1986 through 2024. Researchers and professionals will find the journal invaluable, as it offers comprehensive insights into a range of subjects pertinent to geriatric mental health, with its ranking in Scopus highlighting its academic rigor and relevance (Rank #147/567 in Psychiatry and Mental Health; Rank #37/116 in Geriatrics and Gerontology). Though it operates on a traditional subscription model, the journal's significant contributions to the understanding of psychiatric disorders in the elderly make it a key resource for anyone involved in geriatric care and research.

NEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.

Dementia and Geriatric Cognitive Disorders Extra, published by KARGER in Switzerland, is an esteemed open-access journal dedicated to advancing research in the fields of cognitive neuroscience, geriatrics, and psychiatry. With a commitment to disseminating high-quality research since its inception in 2011, the journal plays a crucial role in highlighting innovative studies that address cognitive disorders associated with aging. As an open-access platform, it ensures that findings are accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, professionals, and students alike. The journal has been recognized for its impact in Cognitive Neuroscience and Psychiatry and Mental Health, achieving a Q3 category ranking, indicating its reputable standing within these fields. By delivering cutting-edge insights and promoting interdisciplinary approaches, Dementia and Geriatric Cognitive Disorders Extra is instrumental in enhancing understanding and treatment of cognitive decline, making it a vital resource for anyone engaged in the study of aging and cognitive health.

PSYCHOLOGICAL MEDICINE is a leading journal in the field of psychiatry and psychology, published by Cambridge University Press. With its ISSN 0033-2917 and E-ISSN 1469-8978, this journal has firmly established itself as a premier platform for cutting-edge research since its inception in 1970. It consistently ranks in the top quartile for both Applied Psychology and Psychiatry and Mental Health, reflecting its exceptional impact in the field, with a 2023 Scopus ranking of #36 out of 567 in Psychiatry and Mental Health, and #21 out of 249 in Applied Psychology. The journal aims to publish comprehensive studies that explore the interplay between psychological phenomena and medical health, contributing vital insights that advance both theoretical understanding and clinical practice. Although it is not an Open Access journal, PSYCHOLOGICAL MEDICINE remains a vital resource for researchers, professionals, and students committed to the scientific investigation of mental health issues.